Sanofi inaugurates Lantus® SoloSTAR® pen assembly plant in its Beijing facility
28 May 2012 | By Sanofi
The group pledges continuous commitment to diabetes management in China...
List view / Grid view
28 May 2012 | By Sanofi
The group pledges continuous commitment to diabetes management in China...
16 May 2012 | By Sanofi
Progress on Jevtana®, Zaltrap™ and JAK2 inhibitor featured...
3 May 2012 | By Sanofi
FDA and the EMA approve 2nd operation for filling and finishing product...
30 April 2012 | By Citigate Dewe Rogerson
Algeta ASA announces that its research collaboration with Sanofi has been extended...
27 April 2012 | By Sanofi
Approval of IMOVAX® POLIO by Japanese health authorities...
20 April 2012 | By Sanofi
Full CARE-MS II results for Alemtuzumab to be unveiled...
19 April 2012 | By Sanofi
Fox Foundation to sponsor a clinical trial to study Sanofi compound...
5 April 2012 | By Sanofi
The FDA has granted Priority Review of the BLA for the investigational agent Zaltrap®...
26 March 2012 | By Sanofi
Data from two Phase 2 trials announced...
16 March 2012 | By Sanofi
Sanofi and Pluromed Inc. have entered into a definitive agreement under which Sanofi is to acquire Pluromed Inc...
5 March 2012 | By Sanofi
At its meeting held on March 5, 2012, the Board of Directors of Sanofi decided to propose the appointment of a new director...
5 March 2012 | By Just:: Health PR
Sanofi has signalled its continuing commitment to support patient groups in the UK with the launch of its 2012 Patient Group Bursary...
2 March 2012 | By Sanofi
Sanofi is pleased to announce the appointment of Jean-Luc Lowinski, as Senior Vice President, Asia Region, effective 1st May...
1 March 2012 | By Sanofi
Genzyme has begun shipping Fabrazyme® (agalsidase beta)...
27 February 2012 | By Sanofi
The creation of the Sanofi-Institut Pasteur Awards announced...